SHENZHEN TARGETRX, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHENZHEN TARGETRX, INC..The latest application filed is for "substituted pyrazole compounds, compositions containing same, and use thereof".

Company Profile

43.42.59

SHENZHEN TARGETRX, INC. - Guangdong N/A CN
Shenzhen Targetrx, inc. - Shenzhen CN
Shenzhen TargetRX, Inc. - Shenzhen, Guangdong CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted pyrazolo[1,5-a]pyrimidines as tropomyosin receptor kinase inhibitors Grant 11,453,672 - Wang , et al. September 27, 2	2022-09-27
Antiviral nucleoside reverse transcriptase inhibitor Grant 11,447,512 - Wang , et al. September 20, 2	2022-09-20
Substituted Pyrazole Compounds, Compositions Containing Same, And Use Thereof App 20220251046 - WANG; Yihan ; et al.	2022-08-11
Antiviral nucleoside reverse transcriptase inhibitor Grant 11,389,463 - Wang , et al. July 19, 2	2022-07-19
Diphenylaminopyrimidine compound for inhibiting kinase activity Grant 11,384,069 - Wang , et al. July 12, 2	2022-07-12
Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity Grant 11,358,973 - Wang , et al. June 14, 2	2022-06-14
Substituted pyrazolo[1,5-a]pyrimidine macrocyclic compound Grant 11,345,703 - Wang , et al. May 31, 2	2022-05-31
(Hetero)arylamide compound for inhibiting protein kinase activity Grant 11,319,317 - Wang , et al. May 3, 2	2022-05-03
Substituted Fused Aromatic Ring Derivative, Composition And Use Thereof App 20220098204 - Wang; Yihan ; et al.	2022-03-31
Indazole compound for use in inhibiting kinase activity, composition and application thereof Grant 11,267,806 - Wang , et al. March 8, 2	2022-03-08
Aminopyrimidine compound and composition comprising same and use thereof Grant 11,267,810 - Wang , et al. March 8, 2	2022-03-08
Dianilinopyrimidine compound for inhibiting kinase activity Grant 11,254,696 - Wang , et al. February 22, 2	2022-02-22
Aminopyrimidine Compound Used For Inhibiting Activity Of Protein Kinase App 20220048891 - Wang; Yihan ; et al.	2022-02-17
Fused Bicyclic Compound For Inhibiting Activity Of Tyrosine Kinase App 20220041607 - Wang; Yihan ; et al.	2022-02-10
Preparation Method For Deuterated Macrocyclic Compound App 20220024908 - Wang; Yihan ; et al.	2022-01-27
Substituted Pyrazolo[1,5-a]pyridine Compound, Composition Containing The Same And Use Thereof App 20220017539 - Wang; Yihan ; et al.	2022-01-20
Dihydroimidazopyrazinone Compound, Composition Including Same, And Use Thereof App 20210386737 - Wang; Yihan ; et al.	2021-12-16
Substituted pyrrolo[3,2-d]pyrimidines and pyrazolo[4,3-d]pyrimidines as tyrosine kinase inhibitors Grant 11,186,578 - Wang , et al. November 30, 2	2021-11-30
Substituted oxadiazole chemical compound and composition containing said chemical compound and use thereof Grant 11,147,802 - Wang , et al. October 19, 2	2021-10-19
Alkynyl(hetero)aromatic Compound For Inhibiting Protein Kinase Activity App 20210284646 - Wang; Yihan ; et al.	2021-09-16
Diarylpyrazole Compound, Composition Comprising Same, And Use Thereof App 20210283132 - Wang; Yihan ; et al.	2021-09-16
Amino pyrimidine compound for inhibiting protein tyrosine kinase activity Grant 11,111,233 - Wang , et al. September 7, 2	2021-09-07
Alkynyl (hetero) Aromatic Ring Compounds Used For Inhibiting Protein Kinase Activity App 20210269448 - Wang; Yihan ; et al.	2021-09-02
(Hetero)arylamide compound for inhibiting protein kinase activity Grant 11,091,462 - Wang , et al. August 17, 2	2021-08-17
Substituted Oxadiazole Chemical Compound And Composition Containing Said Chemical Compound And Use Thereof App 20210186933 - Wang; Yihan ; et al.	2021-06-24
(hetero)arylamide Compound For Inhibiting Protein Kinase Activity App 20210171517 - Wang; Yihan ; et al.	2021-06-10
Di(hetero)aryl Macrocyclic Compound For Inhibiting Protein Kinase Activity App 20210171542 - Wang; Yihan ; et al.	2021-06-10
Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof Grant 10,995,103 - Wang , et al. May 4, 2	2021-05-04
Substituted Pyrazolo[1,5-a]pyrimidine Compound And Pharmaceutical Composition And Use Thereof App 20210107906 - WANG; Yihan ; et al.	2021-04-15
Novel Antiviral Nucleoside Reverse Transcriptase Inhibitor App 20210093650 - Wang; Yihan ; et al.	2021-04-01
Substituted Diamino Heterocyclic Carboxamide Compound And A Composition Containing The Compound And Use Thereof App 20210094939 - Wang; Yihan ; et al.	2021-04-01
Dianilinopyrimidine Compound For Inhibiting Kinase Activity App 20210087213 - Wang; Yihan ; et al.	2021-03-25
Fused Bicyclic Compound For Inhibiting Activity Of Tyrosine Kinase App 20210070758 - Wang; Yihan ; et al.	2021-03-11
Substituted Pyrazolo[1,5-a]pyrimidine Macrocyclic Compound App 20210047330 - WANG; Yihan ; et al.	2021-02-18
Macrocycle And Composition Comprising Thereof App 20210046058 - Wang; Yihan ; et al.	2021-02-18
Substituted Pyrrolotriazine Compound, Pharmaceutical Composition Thereof And Use Thereof App 20210040101 - WANG; Yihan ; et al.	2021-02-11
Arylphosphine Oxides For Inhibiting Kinase Activity App 20210009613 - Wang; Yihan ; et al.	2021-01-14
(Hetero)arylamide compound for inhibiting protein kinase activity Grant 10,875,853 - Wang , et al. December 29, 2	2020-12-29
(hetero)arylamide Compound For Inhibiting Protein Kinase Activity App 20200377473 - WANG; Yihan ; et al.	2020-12-03
Substituted heteroaryl compound, composition containing same, and application thereof Grant 10,851,062 - Wang , et al. December 1, 2	2020-12-01
Antiviral Nucleoside Reverse Transcriptase Inhibitor App 20200369696 - Wang; Yihan ; et al.	2020-11-26
Substituted Pyridazinone Compound App 20200347035 - Wang; Yihan ; et al.	2020-11-05
Macrocycle and composition comprising thereof Grant 10,780,082 - Wang , et al. Sept	2020-09-22
Benzenesulfonylbenazamide Compound For Inhibiting Bcl-2 Protein And Composition And Use Thereof App 20200216442 - Wang; Yihan ; et al.	2020-07-09
Aminopyrimidine Compound And Composition Comprising Same And Use Thereof App 20200207751 - Wang; Yihan ; et al.	2020-07-02
Substituted Heteroaryl Compound, Composition Containing Same, And Application Thereof App 20200190036 - Wang; Yihan ; et al.	2020-06-18
Indazole Compound For Use In Inhibiting Kinase Activity, Composition And Application Thereof App 20200140419 - Wang; Yihan ; et al.	2020-05-07
Macrocycle And Composition Comprising Thereof App 20200101051 - Wang; Yihan ; et al.	2020-04-02
Diphenylaminopyrimidine Compound For Inhibiting Kinase Activity App 20200071303 - Wang; Yihan ; et al.	2020-03-05
Macrocycle and composition comprising thereof Grant 10,543,199 - Wang , et al. Ja	2020-01-28
Steroidal compound, composition containing the same and use thereof Grant 10,519,193 - Wang , et al. Dec	2019-12-31
(hetero)arylamide Compound For Inhibiting Protein Kinase Activity App 20190382374 - WANG; Yihan ; et al.	2019-12-19
(hetero)arylamide Compound For Inhibiting Protein Kinase Activity App 20190375745 - Wang; Yihan ; et al.	2019-12-12
Substituted heteroaryl compound, composition containing same, and application thereof Grant 10,479,767 - Wang , et al. Nov	2019-11-19
Substituted Boric Acid Compound, Pharmaceutical Composition Comprising Same, And Application Thereof App 20190263835 - Wang; Yihan ; et al.	2019-08-29
Amino Pyrimidine Compound For Inhibiting Protein Tyrosine Kinase Activity App 20190152954 - Wang; Yihan ; et al.	2019-05-23
Substituted Heteroaryl Compound, Composition Containing Same, And Application Thereof App 20190092733 - Wang; Yihan ; et al.	2019-03-28
Macrocycle And Composition Comprising Thereof App 20190060292 - Wang; Yihan ; et al.	2019-02-28
Steroidal Compound, Composition Containing The Same And Use Thereof App 20190040098 - Wang; Yihan ; et al.	2019-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.